| Customization: | Available |
|---|---|
| Material: | Liquid Reagent |
| Quality Guarantee Period: | Two Years |
Indocyanine green (lCG) is a near-infrared fluorescent dye, and protein-bound ICG can be excited by external light with a wavelength range of 750 ~ 810 nm, and emits near-infrared light with a wavelength of about 840nm. Its half-life in blood is about 3 ~ 5 minutes. After entering the blood and binding to protein, it is absorbed by liver cells, then enters the intestine through biliary tract, and finally is excreted with feces.
This is the first indocyanine green injection in China that has passed the double consistency evaluation by Akorn in the United States and Daiichi Sankyo in Japan. With its high purity, low impurity content and optimized storage conditions, lCG has brought more stable and reliable diagnosis and treatment options to the medical community.



Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors and retinal vascular lesions; Intraoperative staining of capsule and internal limiting membrane.
Advantages: Clear choroidal vascular images help accurate diagnosis. Fluorescent staining helps physicians identify and treat the capsule and internal limiting membrane accurately and reduce complications.
Indications: Evaluation of liver reserve function, liver tumor image development, liver segment identification, and biliary tract development.
Advantages: Rapidity, accuracy and safety for evaluating liver reserve function. Enhances structural visibility to improve surgical safety.
Indications: Accurate localization of tumors, image development of lymphatic system and assessment of blood supply.
Advantages: Intuitive judgment of targets to enhance visibility during operations.



Our solutions include high-end medical devices (fluorescence imaging series), fluorescence contrast agent drugs (ICG, targeted contrast agents), and core components (CMOS camera modules, endoscopes). These products have been utilized in more than 500 large hospitals.


Focusing on molecular fluorescence, Raman spectroscopy, AI, and computer-aided drug molecular design (CADD). Holds 131 core invention patents and 7 US invention patents.
Strategic partners with international leaders in Germany and Japan, establishing business with more than 10 overseas countries.
SJ medical